Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Legal Marijuana Market Value to hit $59 Billion by 2025: Global Market Insights, Inc.


News provided by

Global Market Insights, Inc.

30 Oct, 2019, 11:57 GMT

Share this article

Share toX

Share this article

Share toX

SELBYVILLE, Delaware, Oct. 30, 2019 /PRNewswire/ -- Global Legal Marijuana Market revenue expected to surpass USD 59 billion by 2025; according to a new research report by Global Market Insights, Inc. Increasing demand for applications of cannabis in the treatment of chronic pain caused by cancer, neurological disorders, arthritis and HIV/AIDS will significantly drive industry growth across the forecast timeframe. The anecdotal evidence recommends that cannabis or its compounds help relieve acute pain associated with various chronic diseases. Marijuana is composed of cannabidiol (CBD) and tetrahydrocannabinol (THC), that helps in eliminating severe pain or symptoms of nausea. Moreover, rising preference of marijuana over traditional opioid narcotics that cause various lethal side effects will further accelerate medical cannabis market growth over the coming years.

Continue Reading
This image opens in the lightbox
GMI Logo

Rising number of government approvals for medical marijuana in several countries will considerably augment market growth. The U.S. Food & Drug Administration (FDA) has approved various medications made from marijuana extract. For instance, epidiolex; an oral solution is approved for the treatment of seizures and Cesamet is used for curing nausea and vomiting associated with chemotherapy. Hence, increasing number of FDA approvals for cannabis products will provide lucrative growth opportunities. However, stringent government regulations may hamper industry growth to a certain extent. Also, dearth of awareness in several developing economies about the benefits of cannabis and its products will further limit business growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2836 

Applications of medical marijuana include pain management, muscle spasms, nausea, anorexia, seizures and others. Muscle spasms segment of medical marijuana market is anticipated to witness 28.1% growth throughout the analysis timeframe. Benefits of medical cannabis in the treatment of muscle spasms will significantly drive market growth. Acute muscle spasms usually occur when muscles are stressed due to dehydration, overuse, deficiency in potassium or magnesium, or when the patient has poor blood circulation. Hence, increasing incidence of severe muscle spasms will provide lucrative growth opportunities for the industry to flourish.

Legal Marijuana Market Projections, By Application

1.1. Key segment trends

1.2. Pain Management
1.2.1. Market size, by region, 2014 – 2025 (USD Million)
1.2.2. Neuropathic pain
1.2.2.1. Market size, by region, 2014 – 2025 (USD Million)
1.2.3. Cancer pain
1.2.3.1. Market size, by region, 2014 – 2025 (USD Million)
1.2.4. Others
1.2.4.1. Market size, by region, 2014 – 2025 (USD Million)

1.3. Muscle spasms
1.3.1. Market size, by region, 2014 – 2025 (USD Million)

1.4. Nausea
1.4.1. Market size, by region, 2014 – 2025 (USD Million)

1.5. Anorexia
1.5.1. Market size, by region, 2014 – 2025 (USD Million)

1.6. Seizures
1.6.1. Market size, by region, 2014 – 2025 (USD Million)

1.7. Others
1.7.1. Market size, by region, 2014 – 2025 (USD Million)

Based on route of administration, medical marijuana market is bifurcated into inhalation, oral and topical. Oral segment was valued at USD 1.2 billion in 2018 and it is anticipated to grow substantially in the forthcoming years. Orally ingesting marijuana through edible products has been used to treat patients and the outcomes are positive enough to drive segmental growth across the forecast timeframe.

Browse key industry insights spread across 150 pages with 214 market data tables & 8 figures & charts from the report, "Medical Marijuana Market Size By Application (Pain Management, Muscle Spasms, Nausea, Anorexia, Seizures), By Route of Administration (Inhalation, Oral, Topical), By Distribution Channel (Dispensaries, Online), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, Italy, France, Spain, UK, The Netherland, Denmark, Ireland, Argentina, Brazil, Chile, Colombia, Mexico, Australia, Israel), Price Trends, Application Potential, Competitive Market Share & Forecast, 2019 – 2025" in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/medical-marijuana-market

Distribution channel of medical cannabis market include dispensaries and online platforms. Online platform segment is anticipated to hold 42.6% market share by 2025. Increasing awareness amongst people regarding various benefits of medical cannabis will show positive growth trajectory across the projected years. Moreover, rising demand from numerous countries and states to legalize cannabis would fetch more orders online as it is very convenient for people to opt for mail orders.

Canada legal marijuana market accounted for revenue of USD 217.6 million in 2018 and is projected to witness momentous growth during the analysis timeframe. Increasing adoption of medical marijuana due to its several applications in the treatment of chronic diseases has augmented business growth in the country. Furthermore, increasing R&D activities to evaluate the benefits of cannabis in the treatment of several medical conditions will positively boost product demand.

Rising number of countries and states legalizing the use of cannabis as a medical treatment has attracted various players in the industry. Key players operating in the legal marijuana market are Aurora Cannabis, Inc., Aphria, Inc., GW Pharmaceuticals, Medical Marijuana, Inc., The Supreme Cannabis Company, Tilray, Emerald Health Therapeutics, Cannabis Sativa, Inc., and Namaste Technologies Inc.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2836 

Browse Related Reports:

U.S. Legal Marijuana Market Share 2024: The U.S. medical marijuana dispensaries market segment will expand at a robust 13.3% CAGR over the forecast period owing to presence of number of legal dispensaries operating in a most of the states. Prominent industry players in the U.S. market include Canopy Growth, Aurora Cannabis, Inc., Medical Marijuana, Inc., GW Pharmaceuticals, Aphria, Inc., CanniMed Ltd., Tilray, Emerald Health Therapeutics, and United Cannabis.

https://www.gminsights.com/industry-analysis/us-medical-marijuana-market 

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: +1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com 

Logo: https://mma.prnewswire.com/media/661916/GMI.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.